Association of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios With Three-Vessel Coronary Artery Disease:

Ladan Ayazkhoo1, Mohammad Sistanizad1,2, Mohammad Haji Aghajani2

  • 1Department of Clinical Pharmacy, School of Pharmacy Shahid Beheshti University of Medical Sciences Tehran Iran.

Health Science Reports
|April 30, 2026
PubMed

Insights

The neutrophil-to-lymphocyte ratio (NLR) is a significant predictor of severe coronary artery disease (CAD), offering a cost-effective method for risk stratification. While the platelet-to-lymphocyte ratio (PLR) shows association, further research is needed.

Area of Science:

  • Cardiology
  • Inflammation research
  • Biomarker discovery

Background:

  • Coronary artery disease (CAD) is a major global cause of mortality.
  • Inflammation is a key factor in CAD development.
  • Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are emerging inflammatory biomarkers for CAD.

Purpose of the Study:

  • To investigate the association between NLR, PLR, and the severity of CAD, specifically three-vessel disease.
  • To evaluate the predictive value of NLR and PLR in patients undergoing coronary angiography.

Main Methods:

  • A registry-based case-control study involving 300 patients.
  • Patients were categorized into two groups: those with three-vessel CAD (≥50% stenosis) and those with normal coronary arteries.
  • Logistic regression analyses were used to determine the predictive value of NLR and PLR.

Main Results:

  • Patients with three-vessel CAD exhibited significantly higher NLR (≥2.5) and PLR (≥130) compared to controls (p<0.05).
  • An NLR of ≥2.5 was independently associated with a 91% increased odds of three-vessel CAD (OR=1.91, p=0.037).
  • Elevated PLR showed a trend towards association with three-vessel CAD but did not reach statistical significance after adjustment (OR=1.79, p=0.077).

Conclusions:

  • NLR is a significant predictor of severe CAD and a potentially cost-effective biomarker for risk stratification.
  • PLR may be associated with CAD severity, but requires further investigation.
  • Additional inflammatory markers should be explored to improve CAD risk assessment.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K